STACEY HINTON: Open Payments
NPI 1437632874 · CHARLOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 92 payments from 16 companies in 2025. Trend: 2023 $1,476 · 2024 $1,659 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $429 |
| Novo Nordisk Inc | 11 | $261 |
| ABBVIE INC. | 18 | $170 |
| Otsuka America Pharmaceutical, Inc. | 7 | $169 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Amgen Inc. | 4 | $65 |
| Hologic Sales and Service, LLC | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
Products named: CAPLYTA, REXULTI, Ozempic, VRAYLAR, FANAPT, Auvelity, OTEZLA, BREVERA BREAST BIOPSY SYSTEM.
Industry payments across MI — which companies pay providers there.
